Peak TRV Risk Stratification Calculator (Echocardiography Pulmonary Hypertension Assessment)

Peak TRV Risk Stratification: Explanation and Clinical Context Peak tricuspid regurgitant velocity (TRV) is a key echocardiographic parameter used to estimate pulmonary artery systolic pressure (PASP) and assess the probability of pulmonary hypertension (PH). It is derived from continuous-wave Doppler measurement of the tricuspid regurgitation jet and incorporated into the simplified Bernoulli equation (ΔP = 4 × TRV²). According to the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension, TRV is categorized as follows: - < 2.8 m/s: Low probability of PH - 2.8–3.4 m/s: Intermediate probability of PH (consider additional echocardiographic signs such as RV size, interventricular septal flattening, or PA dilation) - > 3.4 m/s: High probability of PH In addition to TRV, the presence of supportive signs in other echocardiographic domains (ventricular morphology, pulmonary artery characteristics, inferior vena cava, and right atrial size) can refine the diagnostic likelihood.

Therefore, TRV should not be interpreted in isolation but within the clinical and imaging context. The estimated systolic pulmonary artery pressure (SPAP) is calculated as: SPAP = 4 × TRV² + RAP (right atrial pressure, typically 5–10 mmHg). Values exceeding 35–40 mmHg suggest possible PH, but invasive confirmation with right heart catheterization remains the diagnostic gold standard.

Clinical Interpretation Summary: - TRV is the cornerstone of non-invasive pulmonary pressure estimation. - High TRV (>3.4 m/s) strongly correlates with elevated mean pulmonary artery pressure and adverse outcomes. - Integration with other echocardiographic and clinical parameters enhances specificity.